跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tilorone
首页
药物
Tilorone
Investigational
Small Molecule
Tilorone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
25
H
34
N
2
O
3
CAS 编号
27591-97-5
UNII ID
O6W7VEW6KS
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds for Enhancing Hypoxia Inducible Factor Activity and Methods of Use
申请人: CORNELL RES FOUNDATION INC
优先权: 2005
US
WO
4 件公开
THE ANTIVIRAL DRUG TILORONE IS A POTENT AND SELECTIVE INHIBITOR OF ACETYLCHOLINESTERASE
申请人: COLLABORATIONS PHARMACEUTICALS INC
优先权: 2020
EP
WO
2 件公开
Medicine for treating pneumoconiosis
申请人: HAITAO XU
优先权: 2010
CN
COMBINATION COMPRISING PARTHENOLIDE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
申请人: UNIV KING ABDULLAH SCI & TECH
优先权: 2013
US
Pharmaceutical composition for treating pneumoconiosis
申请人: JINAN ZHENGQI BIOTECHNOLOGY CO LTD
优先权: 2015
CN
PHARMACEUTICAL FORMULATION FOR THE ELIMINATION OF CAUSATIVE AGENTS OF HERPESVIRAL INFECTIONS FROM THE TISSUES OF A MACROORGANISM
申请人: FARBER BORIS SLAVINOVICH
优先权: 2017
WO
Use of pyronaridine, tilorone, and quinacrine against Marburg virus and other virus infections
申请人: COLLABORATIONS PHARMACEUTICALS INC
优先权: 2020
US
Process for preparation of 2, 7-dihydroxy-9-fluorenones useful for synthesis of tilorone and salts thereof
申请人: COUNCIL SCIENT IND RES
优先权: 2021
CN
Tilorone用于预防/治疗非洲猪瘟病毒感染的应用
申请人: 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心)
优先权: 2022
CN
DRUG COMBINATIONS FOR INHIBITING CORONAVIRUS REPLICATION
申请人: INST NAT RECH SCIENT
优先权: 2022
US
药物
反馈